Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Current Deferred Revenue (2020 - 2025)

HealthLynked (HLYK) has disclosed Current Deferred Revenue for 6 consecutive years, with $25924.0 as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 88.85% to $25924.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25924.0 through Dec 2025, down 88.85% year-over-year, with the annual reading at $25924.0 for FY2025, 88.85% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $25924.0 at HealthLynked, down from $47735.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $575843.0 in Q1 2023, with the low at $25924.0 in Q4 2025.
  • Average Current Deferred Revenue over 5 years is $194557.6, with a median of $176490.5 recorded in 2023.
  • The sharpest move saw Current Deferred Revenue soared 1626.77% in 2023, then crashed 88.85% in 2025.
  • Over 5 years, Current Deferred Revenue stood at $47838.0 in 2021, then soared by 1101.65% to $574847.0 in 2022, then tumbled by 52.72% to $271774.0 in 2023, then decreased by 14.43% to $232545.0 in 2024, then plummeted by 88.85% to $25924.0 in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $25924.0, $47735.0, and $155212.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.